Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Executives, Big Pharma, NCI Among Board of New Personalized Medicine Nonprofit

NEW YORK, Oct. 21 (GenomeWeb News) - Executives from Affymetrix, Genomas, and Genomic Health are part of more than 20 companies, academic centers, and government agencies that have formed the Personalized Medicine Coalition, a nonprofit group, the association said today.


Edward Abrahams, former executive director of the Pennsylvania Biotechnology Association, is the PMC executive director, according to a statement.


The PMC board comprises of executives from Abbott Laboratories, Affymetrix, Amgen, AstraZeneca Pharmaceuticals, the Biotechnology Industry Organization, Genentech, Genomas, Genomic Health, Roche, IBM, Pfizer, and the Pharmaceutical Research and Manufacturers of America. The US National Cancer Institute and the US National Human Genome Research Institute are "also active" as ex-officio members, the statement added.


The PMC will focus on topics including: the implications of privacy laws and intellectual property laws in personalized medicine; global developments in biorepositories; and "the value proposition" of emerging drugs and molecular-based tests, the organization said.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.